Salestools LogoSalestools
Salestools LogoSalestools

Raportul

Analize aprofundate ale finanțării companiilor, strategiilor de creștere și informații de piață de la cele mai inovatoare afaceri din lume

10 rapoarte și mai multe

Actualizat zilnic cu ultimele informații de piață
Supply Chain
CatalystLaunch Software

CatalystLaunch Software raises $153M Series D at $464M valuation

CatalystLaunch Software secures $153M in Series D funding led by DST Global, reaching $464M valuation as it accelerates growth in the supply chain sector.

Jessica Martinez
May 8, 2024
0 min read$153M
Media
AccelerateStack Networks

AccelerateStack Networks raises $36M Series B at $153M valuation

AccelerateStack Networks secures $36M in Series B funding led by Coatue, reaching $153M valuation as it accelerates growth in the media sector.

Michael Rodriguez
Jun 8, 2024
0 min read$36M
AI/ML
AccelerateCore Software

AccelerateCore Software raises $42M Series C at $153M valuation

AccelerateCore Software secures $42M in Series C funding led by Index Ventures, reaching $153M valuation as it accelerates growth in the ai/ml sector.

Michael Rodriguez
Jan 8, 2025
0 min read$42M
Fundraising
Upstream Bio

Upstream Bio Raises $153M in Series B

Upstream Bio, a Biotech company based in Waltham, MA, has raised $153M in Series B at a $800M valuation led by Fidelity, Viking Global.

Fundraising News Team
Sep 10, 2024
0 min read
Fundraising
Strand Therapeutics

Strand Therapeutics Raises $153M in Series B

Strand Therapeutics, a HealthTech company based in Cambridge, MA, has raised $153M in Series B led by Kinnevik, Regeneron Ventures, ICONIQ, Amgen Ventures.

Fundraising News Team
Aug 7, 2025
0 min read
Fundraising
Arthrosi Therapeutics

Arthrosi Therapeutics Raises $153M in Series E

Arthrosi Therapeutics, a Biotech company based in San Diego, CA, has raised $153M in Series E at a $800M valuation led by New Enterprise Associates, RA Capital.

Fundraising News Team
Oct 8, 2025
0 min read
Biotech
Strand Therapeutics

Strand Therapeutics Raises $153M Series B to Transform Biotech

Strand Therapeutics has secured $153M Series B in funding to accelerate growth and innovation in the biotech sector. Synthetic biology company programming mRNA therapies with logic-gated controls for precision oncology treatments...

David Chen
Oct 22, 2025
0 min read$153M Series B
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min read$153M
Biotech
Upstream Bio

Upstream Bio raises $153M Series B at $800M valuation

Upstream Bio raises $153M in Series B at $800M valuation. Developing antibody therapeutics for inflammatory diseases...

Editorial Team
Sep 10, 2024
0 min read$153M
Pagina 1

Afișare 9 rapoarte • Pagina 1 • Categorie: all

Rămâneți înaintea pieței

Primiți perspective săptămânale în inbox. Fără spam, doar inteligență.